Skip to main content
SpringerLink
Log in

TheRET proto-oncogene: A challenge to our understanding of disease pathogenesis

  • Main Topic
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

RET gene alterations as disease-causative mutations have been demonstrated in five different disease entities: Hirschsprung's disease (HD); papillary thyroid carcinoma; and three types of inherited cancer syndromes: multiple endocrine neoplasia (MEN) 2A, MEN 213, and familial medullary thyroid carcinoma. RET is expressed during embryogenesis in a temporally and spatially regulated manner, and plays an important role in the normal development of a variety of cell lineages, particularly in the establishment of the enteric nervous system.RET mutations observed in patients with HD are scattered along the gene without any hot spots, and possess a loss-of-function effect.RET mutations are detected with a higher incidence among familial cases (50%) than sporadic cases (15%–20%), and are more closely associated with long-segment HD than short-segment disease. In contrast to HD mutations, missense mutations observed in MEN 2 syndromes occur at specific codons, and gene rearrangements are characteristic in papillary thyroid carcinoma. Both missense mutations and gene rearrangements act in a dominant fashion, and cause constitutive phosphorylation on the tyrosine of RET and highly enhance RET kinase activity, leading to transforming or oncogenic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Takahashi M, Ritz J, Cooper G (1985) Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42: 581–588

    Article  PubMed  CAS  Google Scholar 

  2. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H (1988) Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3: 571–578

    PubMed  CAS  Google Scholar 

  3. Takahashi M, Buma Y, Hiai H (1989) Isolation of ret protooncogene cDNA with an amino-terminal signal sequence. Oncogene 4: 805–806

    PubMed  CAS  Google Scholar 

  4. Tahira T, Ishizaka Y, Itoh F, Sugimura T, Nagao M (1990) Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene 5: 97–102

    PubMed  CAS  Google Scholar 

  5. Ceccherini I, Bocciardi R, Luo Y, Pasini B, Hofstra R, Takahashi M, Romeo G (1993) Exon structure and flanking intronic sequences of the human RET proto-oncogene. Biochem Biophys Res Commun 196: 1288–1295

    Article  PubMed  CAS  Google Scholar 

  6. Kwok J, Gardner E, Warner J, Ponder B, Mulligan L (1993) Structural analysis of the human ret proto-oncogene using exon trapping. Oncogene 8: 2575–2582

    PubMed  CAS  Google Scholar 

  7. Ishizaka Y, Itoh F, Tahira T, Ikeda I, Sugimura T, Tucker J, Fertitta A, Carrano AV, Nagao M (1989) Human ret protooncogene mapped to chromosome 10g11.2. Oncogene 4: 1519–1521

    PubMed  CAS  Google Scholar 

  8. Schneider R (1992) The human protooncogene ret: a communicative cadherin? TIBS 17: 468–469

    PubMed  CAS  Google Scholar 

  9. Jing S (1996) Cell 85: 1113–1124

    Article  Google Scholar 

  10. Trupp M, Arenas E, Fainzilber M, Nilsson A, Sieber B, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumae U (1996) Functional receptor for GDNF encoded by the c-ret protooncogene. Nature 381: 785–789

    Article  Google Scholar 

  11. Durbec P, Marcos-Gutierrez C, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M (1996) GDNF signalling through the ret receptor tyrosine kinase. Nature 381: 789–793

    Article  Google Scholar 

  12. Treanor J, Goodman L, de Sauvage F, Stone D, Poulson K, Beck C, Gray C, Armanini M, Pollock R, Hefti F (1996) Characterization of a multicomponent receptor for GDNF. Nature 382: 80–83

    Article  Google Scholar 

  13. Lin L, Doherty D, Lile J, Bektesh S, Collins F (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130–1132

    Article  PubMed  CAS  Google Scholar 

  14. Henderson C, Phillips H, Pollock R, Davies A, Lemeulle C, Armanini M, Simpson L, Moffet B, Vandlen R, Koliatsos V (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266: 1062–1064

    Article  PubMed  CAS  Google Scholar 

  15. Tomac A, Lindqvist E, Lin L, Ogren S, Young D, Hoffer B, Olson L (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335–339

    Article  PubMed  CAS  Google Scholar 

  16. Beck K, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen R, Rosethal A, Hefti F (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373: 339–341

    Article  PubMed  CAS  Google Scholar 

  17. Yan Q, Matheson C, Lopez O (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373: 341–344

    Article  PubMed  CAS  Google Scholar 

  18. Oppenheim R, Houenou L, Johnson J, Lin L, Li L, Lo A, Newsome A, Prevette D, Wang S (1995) Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF Nature 373: 344–346

    Article  PubMed  CAS  Google Scholar 

  19. Fusco A, Grieco M, Santoro M, Berlingieri M, Pilotti S, Pierotti M, Della P, Vecchi G (1987) A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 328: 170–172

    Article  PubMed  CAS  Google Scholar 

  20. Grieco M, Santoro M, Berlingieri M, Melillo R, Donghi R, Bongarzone I, Pierotti M, Della Porta D, Fusco A, Vecchio G (1990) PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60: 557–563

    Article  PubMed  CAS  Google Scholar 

  21. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367: 377–378

    Article  PubMed  CAS  Google Scholar 

  22. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367: 378–380

    Article  PubMed  CAS  Google Scholar 

  23. Donis-Keller H, Dou S, Chi D, Carlson K, Yoshima K, Lairmore T, HoweJ, Moley J, Goodfellow P, Wella S Jr. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2: 851–856

    Article  PubMed  CAS  Google Scholar 

  24. Mulligan L, Kwok J, Healey C, Elsdon M, Eng C, Gardner E, Love D, Mole S, Moore J, Papi L (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458–460

    Article  PubMed  CAS  Google Scholar 

  25. Mulligan L, Eng C, Healey C, Clayton D, Kwok J, Gardner E, Ponder M, Frilling A, Jackson C, Lehnert H (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 6: 70–74

    Article  PubMed  CAS  Google Scholar 

  26. Hofstra R, Landsvater R, Ceccherini I, Stulp R, Stelwagen T, Luo Y, Pasini B, Hoppener J, van Amstel H, Romeo G (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367: 375–376

    Article  PubMed  CAS  Google Scholar 

  27. Eng C, Smith D, Mulligan L, Nagai M, Healey C, Ponder M, Gardner E, Scheumann G, Jackson C, Tunnacliffe A (1994) Point mutation within the tyrosine kinase domain of the RET protooncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 3: 237–241

    Article  PubMed  CAS  Google Scholar 

  28. Carlson K, Dou S, Chi D, Scavarda N, Toshima K, Jackson C, Wells SJ, Goodfellow P, Donis-Keller H (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia 2B. Proc Natl Acad Sci U S A 91: 1579–1583

    Article  PubMed  CAS  Google Scholar 

  29. Schiller M, Levy R, Shawa R, Abu-Dalu K, Gorenstein A, Katz S (1990) Familial Hirschsprung's disease - a report of 22 affected siblings in four families. J Pediatr Surg 25: 322–325

    Article  PubMed  CAS  Google Scholar 

  30. Stannard V, Fowler C, Roginson L, Besner G, Glick P, Allen J, Jewett T, Cooney D (1990) Familial Hirschsprung's disease: report of autosomal dominant and probable autosomal recessive X-linked kindreds. J Pediatr Surg 26: 591–594

    Article  Google Scholar 

  31. Badner J, Sieber W Garver K, Chakravarti A (1990) A genetic study of Hirschsprung disease. Am J Genet 46: 568–580

    CAS  Google Scholar 

  32. Schimke R (1984) Genetic aspects of multiple endocrine neoplasia. Annu Rev Med 35: 25–31

    Article  PubMed  CAS  Google Scholar 

  33. Verdy M, Weber A, Roy C, Morin C, Cadotte M, Brochu P (1982) Hirschsprung's disease in a family with multiple endocrine neoplasia type 2. J Pediatr Gastroenterol Nutr 1: 603–607

    Article  PubMed  CAS  Google Scholar 

  34. Schimke R, Hartmann W Prout T, Rimoin D (1968) Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. N Engl J Med 279: 1–7

    Article  PubMed  CAS  Google Scholar 

  35. Chong G, Beahrs O, Sizemore G, Woolner L (1975) Medullary carcinoma of the thyroid gland. Cancer 33: 695–704

    Article  Google Scholar 

  36. Farndon J, Leight G, Dilley W Baylin S, Smallridge R, Harrison T, Wells SJ (1986) Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct entity. Br J Surg 73: 278–281

    Article  PubMed  CAS  Google Scholar 

  37. Pachnis V, Mankoo B, Costantini F (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119: 1005–1017

    PubMed  CAS  Google Scholar 

  38. Avantaggiato V, Dathan N, Grieco M, Fabien N, Lazzaro D, Fusco A, Simeone A, Santoro M (1994) Developmental expression of the RET protooncogene. Cell Growth Diff 5: 305–311

    PubMed  CAS  Google Scholar 

  39. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M, Asai J (1995) Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene 10: 191–198

    PubMed  CAS  Google Scholar 

  40. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor ret. Nature 367: 380–383

    Article  PubMed  CAS  Google Scholar 

  41. Sanchés M, Silos-Santiago I, Frisen J, He B, Lira S, Barbacid M (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF Nature 382: 70–73

    Article  Google Scholar 

  42. Pichel J, Shen L, Sheng H, Granholm A, Drago J, Grinberg A, Lee E, Huang S, Saarma M, Hoffer B (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382: 73–76

    Article  Google Scholar 

  43. Moore M, Klein R, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt L, Ryan A, Carver-Moore K, Rosenthal A (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature 382: 76–79

    Article  Google Scholar 

  44. Kusafuka T, Puri P. Altered RET gene mRNA expression in Hirschsprung's disease. J Pediatr Surg: (in press)

  45. Martucciello G, Favre A, Takahashi M, Jasonni V (1995) Immunohistochemical localization of RET protein in Hirschsprung's disease. J Pediatr Surg 30: 433–436

    Article  PubMed  CAS  Google Scholar 

  46. Tam P, Gould S, Martucciello G, Biddolph S, Takahashi M, Jasonni V (1996) Ret protein in the human fetal rectum. J Pediatr Surg 31: 568–571

    Article  Google Scholar 

  47. Yntema C, Hammond W (1954) The origin of intrinsic ganglia of trunk viscera from vagal neural crest in the chick embryo. J Comp Neurol 101: 515–542

    Article  PubMed  CAS  Google Scholar 

  48. Le Douarin N, Teillet M (1973) The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morph 30: 31–48

    PubMed  Google Scholar 

  49. Durbec P, Larsson-Blomberg L, Schuchardt A, Costantini F, Pachnis V (1996) Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts. Development 122: 349–358

    Google Scholar 

  50. Lo L, Anderson D (1995) Postmigratory neural crest cells expressing c-RET display restriction developmental and proliferative capacities. Neuron 15: 527–539

    Article  PubMed  CAS  Google Scholar 

  51. Shah N, Marchionni M, Isaacs I, Stroobant P, Anderson D (1994) Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 77: 349–360

    Article  PubMed  CAS  Google Scholar 

  52. Stemple D, Anderson D (1992) Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 71: 973–985

    Article  PubMed  CAS  Google Scholar 

  53. Martucciello G, Bicocchi M, Dodero P, Lerone M, Silengo Cirillo M, Puliti A, Gimelli G, Romeo G, Jasoni V (1992) Total colonic aganglionosis associated with interstitial deletion of the long arm of chromosome 10. Pediatr Surg Int 7: 308–310

    Article  Google Scholar 

  54. Luo Y, Ceccherini I, Pasini B, Matera I, Bicocchi M, Barone V, Bocciardi R, Kaariainen H, Weber D, Devoto M (1993) Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. Hum Mol Genet 2: 1803–1808

    Article  PubMed  CAS  Google Scholar 

  55. Fewtrell M, Tam P, Thomson A, Fitchett M, Currie J, Huson S, Mulligan L (1994) Hirschsprung's disease associated with deletion of chromosome 10 (g11.2q21.2): a further link with the neurocristopathies? J Med Genet

  56. Lyonnet S, Bolino A, Pelet A, Abel L, Nihoul-Fekete C, Briard M, Mok-Siu V, Kaariainen H, Martucciello G, Lerone M (1993) A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet 4: 346–350

    Article  PubMed  CAS  Google Scholar 

  57. Angrist M, Kauffman E, Slaugenhaupt S, Matise T, Puffenberger E, Washington S, Lipson A, Cass D, Reyna T, Weeks D (1993) A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10. Nat Genet 4: 351–356

    Article  PubMed  CAS  Google Scholar 

  58. Chakravarti A (1996) Endothelin receptor-mediated signaling in Hirschsprung disease. Hum Mol Genet 5: 303–307

    Google Scholar 

  59. Angrist M, Bolk S, Thiel B, Puffenberger E, Hofstra R, Buys C, Cass D, Chakravarti A (1995) Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 4: 821–830

    Article  PubMed  CAS  Google Scholar 

  60. Attie T, Pelet A, Edery P, Eng C, Mulligan L, Amiel J, Boutrand L, Beldjord C, Nihoul-Fekete C, Munnich A (1995) Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 4: 1381–1386

    Article  PubMed  CAS  Google Scholar 

  61. Kusafuka T, Wang Y, Puri P (1996) Mutation analysis of the RET, the endothelin-B receptor and the endothelin-3 genes in sporadic patients with Hirschsprung's disease. J Pediatr Surg: (in press)

  62. Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A, Yanagisawa M (1994) Targeted and natural (piebaldlethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79: 1267–1276

    Article  PubMed  CAS  Google Scholar 

  63. Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, Chakravarti A (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79: 1257–1266

    Article  PubMed  CAS  Google Scholar 

  64. Kusafuka T, Puri P (1997) Mutations of the endothelin-B receptor and endothelin-3 genes in Hirschsprung's disease. Pediatr Surg Int: (in press)

  65. Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, Yanagisawa M (1994) Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79: 1277–1285

    Article  PubMed  CAS  Google Scholar 

  66. Lane P, Liu H (1984) Association of megacolon with a new dominant spotting gene (Dom) in the mouse. J Hered 75: 435–439

    PubMed  CAS  Google Scholar 

  67. El-Halaby E, Coran A (1994) Hirschsprung's disease associated with Ondine's curse: report of three cases and review of the literature. J Pediatr Surg 29: 530–535

    Article  PubMed  CAS  Google Scholar 

  68. Barone V, Weber D, Luo Y, Brancolini V, Devoto M, Romeo G (1996) Exclusion of linkage between RET and neuronal intestinal dysplasia type B. Am J Med Genet 62: 195–198

    Article  Google Scholar 

  69. Bolk S, Angrist M, Schwartz S, Silvestri J, Weeke-Mayer D, Chakravarti A (1996) Congenital central hypoventilation syndrome: Mutation analysis of the receptor tyrosine kinase RET. Am J Med Genet 63: 603–609

    Article  Google Scholar 

  70. Pasini B, Borrello MG, Greco A, Bongarzone I, Luo Y, Mondellini P, Alberti L, Miranda C, Arighi E, Bocciardi R (1995) Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet 10: 35–40

    Article  PubMed  CAS  Google Scholar 

  71. Pierotti M, Santoro M, Jenkins R, Sozzi G, Bongarzone I, Grieco M, Monzini N, Miozzo M, Herrmann M, Fusco A (1992) Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Nad Acad Sci U S A 89: 1616–1620

    Article  CAS  Google Scholar 

  72. Bongarzone I, Monzini N, Borrello M, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti M (1993) Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol Cell Biol 13: 358–366

    PubMed  CAS  Google Scholar 

  73. Sozzi G, Bongarzone I, Miozzo M, Berrello M, Blutti M, Pilotti S, Della Porta G, Pierotti M (1994) A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence, in papillary thyroid carcinoma. Genes Chromosom Cancer 9: 244–250

    Article  PubMed  CAS  Google Scholar 

  74. Bongarzone I, Butti M, Coronelli S, Borrello M, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G, Pierotti M (1994) Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinoma. Cancer Res 54: 2979–2985

    PubMed  CAS  Google Scholar 

  75. Santoro M, Dathan N, Berlingieri M, Bongarzone I, Paulin C, Grieco M, Pierotti M, Vecchio G, Fusco A (1994) Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9: 509–516

    PubMed  CAS  Google Scholar 

  76. Minoletti F, Butti M, Coronelli S, Miozzo M, Sozzi G, Pilotti S, Tunnacliffe A, Pierotti M, Bongarzone I (1994) The two genes generating RET/PTC3 are localized in chromosomal band 10g11.2. Genes Chromosom Cancer 11: 51–57

    Article  PubMed  CAS  Google Scholar 

  77. Santoro M, Carlomagno F, Hay I, Herrmann M, Grieco M, Melillo R, Pierotti M, Bougarzone I, Della Porta G, Berger N (1992) Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89: 1517–1522

    Article  PubMed  CAS  Google Scholar 

  78. Santoro M, Sabino N, Ishizaka Y, Ushijima T, Carlomagno F, Cerrato A, Grieco M, Battaglia C, Martelli M, Paulin C (1993) Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. Br J Cancer 68: 460–464

    Article  PubMed  CAS  Google Scholar 

  79. Ito T, Seyama T, Iwamoto K, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N, Akiyama M (1993) In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res 53: 2940–2943

    PubMed  CAS  Google Scholar 

  80. Ito T, Seyama T, Iwamoto K, Mizuno T, Tronko N, Komissarenko I, Cherstovoy E, Satow Y, Takeichi N, Dohi K (1994) Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident. Lancet 344: 259

    PubMed  CAS  Google Scholar 

  81. Simpson N, Kidd K, Goodfellow P, McDermid H, Myers S, Kidd J, Jackson C, Duncan A, Farrer L, Brasch K (1987) Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328: 528–530

    Article  PubMed  CAS  Google Scholar 

  82. Mathew C, Chin K, Easton D, Thorpe K, Carter C, Lion G, Fong S, Bridges C, Haak H, Nieuwenhuijzen Krusman A (1987) A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328: 527–528

    Article  PubMed  CAS  Google Scholar 

  83. Lairmore T, Howe J, Korte J, Dilley W, Aine I, Aine E, Wells S, Donis-Keller H (1991) Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A. Genomics 9: 181–192

    Article  PubMed  CAS  Google Scholar 

  84. Carson N, Wu J, Jackson C, Kidd K, Simpson N (1990) The mutation for medullary thyroid carcinoma with parathyroid tumours (MTC with PTs) is closely linked to the centromeric region of chromosome 10. Am J Hum Genet 47: 946–951

    PubMed  CAS  Google Scholar 

  85. Gardner E, Papi L, Easton D, Cummings T, Jackson C, Kaplan M, Love D, Mole S, Moore J, Mulligan L (1993) Genetic linkage studies map the multiple endocrine neoplasia type 21oci to a small interval on chromosome 10g11.2. Hum Mol Genet 2: 241–246

    Article  PubMed  CAS  Google Scholar 

  86. Mole S, Mulligan L, Healey C, Ponder B, Tunnacliffe A (1993) Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10g11.2. Hum Mol Genet 2: 247–252

    Article  PubMed  CAS  Google Scholar 

  87. Mulligan I, Eng C, Attie T, Lyonnet S, Marsh D, Hyland V, Robinson B, Frilling A, Verellen-Dumoulin C, Safar A (1994) Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet 3: 2163–2167

    Article  PubMed  CAS  Google Scholar 

  88. Mulligan L, Marsh D, Robinson B, Schuffenecker I, Zedenius J, Lips C, Gagel R, Takai S, Noll W Fink M (1995) Genotypephenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Intern Med 238: 343–346

    Article  PubMed  CAS  Google Scholar 

  89. Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir G (1994) RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum Mol Genet 3: 1939–1943

    Article  PubMed  CAS  Google Scholar 

  90. Eng C, Smith D, Mulligan L, Healey C, Zvelebil M, Stonehouse T, Ponder M, Jackson C, Waterfield M, Ponder B (1995) A novel point mutation in the tyrosine kinase domain of the RET protooncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 10: 509–513

    PubMed  CAS  Google Scholar 

  91. Bolino A, Schuffenecker I, Luo Y, Seri M, Silengo M, Tocco T, Chabrier G, Houdent C, Murat A, Schlumberger M (1995) RET mutations in exons 13 and 14 of FMTC patients. Oncogene 10: 2415–2419

    PubMed  CAS  Google Scholar 

  92. Hanks S, Quinn A, Hunter T (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domain. Science 241: 42–52

    Article  PubMed  CAS  Google Scholar 

  93. Eng C, Mulligan L, Smith D, Healey C, Frilling A, Raue F, Neumann H, Pfragner R, Behmel A, Lorenzo M (1995) Mutation of the RET proto-oncogene in sporadic medullary thyroid carcinoma. Genes Chromosom Cancer 12: 209–212

    Article  PubMed  CAS  Google Scholar 

  94. Tong Q, Li Y, Smanik P, Fithian L, Xing S, Mazzaferri E, Jhiang S (1995) Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene. Oncogene 10: 1781–1787

    PubMed  CAS  Google Scholar 

  95. Asai N, Iwashita T, Matsuyama M, Takahashi M (1995) Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 15: 1613–1619

    PubMed  CAS  Google Scholar 

  96. Borrello M, Smith D, Pasini B, Bongarzone I, Greco A, Lorenzo M, Arighi E, Miranda C, Eng C, Alberti L (1995) RET activation by germline MEN 2A and MEN 2B mutations. Oncogene 11: 2419–2427

    PubMed  CAS  Google Scholar 

  97. Santoro M, Carlomango F, Romano A, Bottaro D, Dathan N, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus M (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 267: 381–383

    Article  PubMed  CAS  Google Scholar 

  98. Songyang Z, Carraway KI, Eck M, Harrison S, Feldman R, Mohammadi M, Schlessinger J, Hubbard S, Smith D, Eng C (1995) Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373: 536–539

    Article  PubMed  CAS  Google Scholar 

  99. Borst M, VanCamp J, Peacock M, Decker R (1995) Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease. Surgery 117: 386–391

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children's Research Centre, Our Lady's Hospital for Sick Children, 12, Crumlin, Dublin, Ireland

    T. Kusafuka & P. Puri

Authors
  1. T. Kusafuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Puri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kusafuka, T., Puri, P. TheRET proto-oncogene: A challenge to our understanding of disease pathogenesis. Pediatr Surg Int 12, 11–18 (1997). https://doi.org/10.1007/BF01194794

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01194794

Key words

Search

Navigation